MedPath

Treatment to prevent the increase in myopia among childre

Phase 3
Conditions
Health Condition 1: H521- Myopia
Registration Number
CTRI/2023/12/060537
Lead Sponsor
AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

5-15 year children with documented myopia progression of =0.5D/year, myopic refractive error -1 D to -6 D, Best corrected visual acuity 6/9 or better in both the eyes.

Exclusion Criteria

Previously on myopia control intervention, history of ocular surgery, anisometropia ( > 1D), high astigmatism ( > -1.5D), children with strabismus, amblyopia, ocular pathology including poor ocular surface, corneal opacities, staphyloma etc., high astigmatism ( > -1.5D), not willing to follow-up/giving consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Spherical Equivalent Refractive errorTimepoint: Baseline (day 0), 2 week, 6 month, 12 month, 18 month and 24 month.
Secondary Outcome Measures
NameTimeMethod
Change in amplitude of accommodationTimepoint: Baseline (day 0), 2 week, 6 month, 12 month, 18 month and 24 month.;Change in ocular biometric parameters (axial length, keratometry, Lens power)Timepoint: Baseline (day 0), 2 week, 6 month, 12 month, 18 month and 24 month.;Change in pupil sizeTimepoint: Baseline (day 0), 2 week, 6 month, 12 month, 18 month and 24 month.;Effect on higher order aberrations, retinal image quality and contrast sensitivityTimepoint: Baseline (day 0), 2 week, 6 month, 12 month, 18 month and 24 month.
© Copyright 2025. All Rights Reserved by MedPath